Relmada Therapeutics, Inc. has filed a lawsuit against Laidlaw & Company at the U.S District Court of Nevada. Filed on Jan 26, 2016, the clinical firm intends to add additional charges against Laidlaw due to a breach of fiduciary duties owed to the plaintiff. Such a charge is based on the defendant’s unethical release of confidential information obtained from Relmada. Additionally, the plaintiff intends to obtain financial damages incurred through legal fees and damage control caused by Laidlaw’s actions.
Before the recent charges, the Nevada District Court had previously issued an injunction against Laidlaw’s directors, James Ahern and Matthew Eitner due to the dissemination of false information. Relmada firmly believes that the defendant should pay damages suffered as a result of Laidlaw’s impulsive actions. Moreover, they ought to be prevented from harming the Company’s reputation in future.
Relmada’s Relationship with Laidlaw
Laidlaw had served as the Company’s chief investment banker for several years. Through such an appointment, they were tasked with facilitating financial transactions between the Company and other institutions. Their involvement played an essential role in the Relmada’s merger with Camp Nine, Inc. Such a bold investment opportunity put the Company on the map and promoted more business interactions.
After a series of successful investment opportunities, Laidlaw sought a seat on the Company’s Board of Directors. It is common knowledge that Directors play a significant role in evaluating lucrative contracts with both foreign and domestic investors. The power to appoint the majority of the Directors was too much of a bargain to part away with. The current predicament between the two firms can be traced back to this single incident.
A close look into Laidlaw’s past reveals an astonishing number of complaints filed by customers. For starters, they are accused of poor implementation of policies and failure to verify checks offered to clients between 2007 and 2012.
Laidlaw & Company’s Profile
Laidlaw is an investment and brokerage firm that specializes in financial solutions and investment advice to both public and private institutions and wealthy clients. Based in the U.K, the enterprise has exponentially grown to offers services worldwide.